| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −7.8× | −1.7× | |
| Price / Book | 0.1× | 2.0× | |
| Price / Sales | 1.2× | 4.0× | |
| Price / Free cash flow | −0.8× | −1.6× | |
| EV / EBITDA | 1.0× | −1.2× | |
| Earnings yield | −12.8% | −14.6% | |
| Free cash flow yield | −120.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,249.23 | −0.62% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.61 | −0.76% | $611.17B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.79 | −0.57% | $501.49B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.32 | +0.22% | $361.12B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.30 | −1.13% | $356B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.40 | −0.15% | $278.23B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.09 | −0.19% | $256.04B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $677.35 | −1.83% | $250.45B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $427.64 | −1.12% | $231.2B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.40 | −1.15% | $191.45B | 22.8× | 37.5% | +32.0% |
